Veeva Systems has announced that LEO Pharma is using Veeva Vault Safety to optimize its safety operations. With this foundation, the company can incorporate affiliates into safety workflows, boost operational efficiencies, ensure compliance, and unify its global pharmacovigilance data on one platform.
“LEO Pharma is deeply committed to the safety of patients using its products,” said Pilar Carrero, vice president of global safety at LEO Pharma in a press release. “With Veeva Vault Safety, we now have real-time visibility into adverse events and data transparency for affiliates that helps us work even better together.”
Vault Safety is helping LEO Pharma improve oversight of case intake, processing, submission, and distribution while simplifying safety workflows and eliminating data reconciliation with affiliates and partners. By standardizing drug development on Veeva Development Cloud, LEO Pharma can better connect safety to other crucial business areas like clinical, regulatory, and quality.
“Now, all parties have visibility into case data, ownership, and status, facilitating improved collaboration and sharing of learnings,” said John Lawrie, vice president of Vault Safety at Veeva in a press release. “Veeva is happy to partner with LEO Pharma to make its safety operations simpler and more effective.”
Vault Safety is a safety case management system that enables adverse event intake, processing, and submission for clinical and marketed products. It is part of Veeva Development Cloud.
LEO Pharma Connects Affiliates with Veeva Vault Safety to Transform Safety Operations. (2023, October 3). Veeva.
